Skip to main content
. Author manuscript; available in PMC: 2010 Nov 1.
Published in final edited form as: Dev Neurobiol. 2009 Nov;69(13):871–884. doi: 10.1002/dneu.20747

Figure 3. VEGF signaling in cultured primary MNs.

Figure 3

Western blotting of primary MNs treated with VEGF. (A) Time course of Akt and p44/42 MAPK phosphorylation in response to VEGF (250 ng/ml) treatment. (B) Pretreatment (1 h) with inhibitors to the PI3K/Akt pathway (LY294002; 20µM), p44/42 MAPK pathway (U0126; 20µM), and VEGFR2 (SU1948; 20µM) prevent activation of the respective signaling pathways in response to VEGF treatment.